[en] OBJECTIVE: The aim of this study was to evaluate the efficacy and tolerability of meloxicam compared with diclofenac in patients with osteoarthritis of the lumbar spine. SUBJECTS: 229 patients with radiologically confirmed osteoarthritis of the lumbar spine. TREATMENT AND METHODS: Once-daily meloxicam 7.5 mg tablet or diclofenac 100 mg slow release tablet. Efficacy and tolerability parameters were assessed at baseline and after 3, 7 and 14 days of treatment. RESULTS: The two drugs had equal short-term efficacy, with pain on motion of lumbar spine significantly (p<0.05) decreased at Day 3. Secondary efficacy variables were also significantly improved at Days 3, 7 and 14. There were no statistically significant differences between the two drugs, although the global tolerability of meloxicam was significantly better than for diclofenac, as assessed by the investigators (p = 0.0072) and the patients (p = 0.049). CONCLUSIONS: Meloxicam and diclofenac were equivalent in relieving the acute pain associated with osteoarthritis of the lumbar spine. However, meloxicam was much better tolerated.
Disciplines :
General & internal medicine
Author, co-author :
Valat, J P
Accardo, S
REGINSTER, Jean-Yves ; Centre Hospitalier Universitaire de Liège - CHU > Médecine de l'appareil locomoteur
Wouters, Murielle ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Département des sciences biomédicales et précliniques
Hettich, M
Lieu, P L
Language :
English
Title :
A comparison of the efficacy and tolerability of meloxicam and diclofenac in the treatment of patients with osteoarthritis of the lumbar spine.
Publication date :
2001
Journal title :
Inflammation Research
ISSN :
1023-3830
eISSN :
1420-908X
Publisher :
Springer Science & Business Media B.V., Basel, Switzerland
Richardson C., Emery E. (1995) New therapies for rheumatoid arthritis. Br J Clin Pract 49:135-139.
Graham D.Y., White R.H., Moreland L.W., Schubert T.T., Katz R., Jaszewski R. (1993) Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs. Ann Intern Med 119:257-262.
Vane J.R., Botting R.M. (1997) Mechanism of action of aspirin-like drugs. Semin Arthritis Rheum 26(6 SUPPL. 1):2-10.
Frölich J.C. (1995) Prostaglandin endoperoxide synthetase isoenzymes: The clinical relevance of selective inhibition. Ann Rheum Dis 54:942-943.
Patrignani P., Panara M.R., Santini G., Sciulli M.G., Padovano R., Cipollone F. (1996) Differential inhibition of the cyclooxygenase activity of prostaglandin endoperoxide synthase isozymes in vitro and ex vivo in man. Prostaglandins Leukot Essent Fatty Acids , abstr P115; 55(SUPPL. 1):98.
Churchill L., Graham A.G., Shih C.-K., Pauletti D., Farina P.R., Grob P.M. (1996) Selective inhibition of human cyclo-oxygenase-2 by meloxicam. Inflammopharmacology 4:125-135.
Hawkey C.J. (1997) The gastroenterologist's caseload: Contribution of the rheumatologist. Semin Arthritis Rheum 26(6 SUPPL. 1):11-15.
Distel M., Mueller C., Bluhmki E., Fries J. (1996) Safety of meloxicam: A global analysis of clinical trials. Br J Rheumatol 35(SUPPL. 1):68-77.
Hawkey C., Kahan A., Steinbrück K., Alegre C., Baumelou E., Begaud B. (1998) Gastrointestinal tolerability of meloxicam compared to diclofenac in osteoarthritis patients. Br J Rheumatol 37:937-945.
Dequeker J., Hawkey C., Kahan A., Steinbrück K., Alegre C., Baumelou E. (1998) Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: Results of the safety and efficacy large-scale evaluation of COX-inhibiting therapies (SELECT) trial in osteoarthritis. Br J Rheumatol 37:946-951.
Linden B., Distel M., Bluhmki E. (1996) A double-blind study to compare the efficacy and safety of meloxicam 15 mg with piroxicam 20 mg in patients with osteoarthritis of the hip. Br J Rheumatol 35(SUPPL. 1):35-38.
Hosie J., Distel M., Bluhmki E. (1996) Meloxicam in osteoarthritis: A 6-month, double-blind comparison with diclofenac sodium. Br J Rheumatol 35(SUPPL. 1):39-43.
Prouse P.J., Bevis P.J., Bluhmki E., Distel M. (1996) Evaluation of the safety, tolerability, and efficacy of meloxicam tablets in patients with osteoarthritis. Clin Ther 18:429-439.
Symmons D.P.M., Van Hemert A.M., Vandenbroucke J.P., Valkenburg H.A. (1991) A longitudinal study of back pain and radiological changes in the lumbar spines of middle aged women. II. Radiographic findings. Ann Rheum Dis 50:162-166.
MacRae I.F., Wright V. (1969) Measurement of back movement. Ann Rheum Dis 28:584-589.
Roland M., Morris R. (1983) A study of the natural history of back pain. Part I: Development of a reliable and sensitive measure of disability in low back pain. Spine 8:141-144.
Peyron J.G., Altman R.D. (1992) The epidemiology of osteoarthritis. Osteoarthritis, Diagnosis and Medical/Surgical Management, 2nd ed. , Moskowitz RW, Howell DS, Goldberg M, et al., editors. Philadelphia, PA:WB Saunders Co; 15-37.
Frymoyer J.W. (1988) Back pain and sciatica. N Engl J Med 318:291-300.
